State Definitions of “Medical Device” Do Not Always Match FDA

A product’s FDA classification does not determine how every state regulates it. State definitions, licensing categories, and regulatory frameworks can differ significantly, making state-by-state analysis essential.

One Product, Multiple Legal Definitions

A product’s status as a medical device under federal law does not determine how every state will categorize it.

FDA applies the definition in section 201(h)(1) of the Federal Food, Drug, and Cosmetic Act. Broadly, that definition covers instruments, implants, in vitro reagents and similar articles intended for diagnosis, treatment, prevention or an effect on the body that do not achieve their primary intended purpose through chemical action or metabolism.

States draft and administer their own statutes.

A state may reproduce or incorporate the federal definition, use similar wording with important additions or omissions, or create a narrower category focused only on products whose sale or use is restricted.

Other statutes use “device” without supplying a complete definition, leaving the regulator to interpret the term through related provisions, rules, applications or established practice.

FDA Definitions Do Not Control State Licensing

The result can be counterintuitive.

A product treated by FDA as a medical device may fall outside a particular state licensing category, while another state may regulate it as a prescription device, legend device, durable medical equipment item, home care product or another specifically defined category.

What Is a Legend Device?

A “legend device” is generally a device that may be sold, distributed or used only by, on the prescription of, or on the order of an appropriately licensed practitioner.

The word “legend” refers to the restrictive statement—or legend—appearing on the label, such as “Rx only” or language stating that federal law restricts the device to sale by or on the order of a licensed practitioner.

The term therefore describes a restriction on sale or use.

It does not describe FDA Class I, II or III status, and it is not a premarket pathway.

A Class I or 510(k)-exempt device may still be a legend device, while another regulated device may be sold over the counter.

Why the State Framework Matters

Even where two states regulate the same product, they may do so through different legal structures.

Responsibility may sit with a board of pharmacy, department of health, professional-regulation department, drug-and-device program or another agency.

One state may require a medical-device distributor registration, another may regulate only prescription or legend devices, and another may address the product through a DME, pharmacy, home-care or general wholesale framework.

Ask the Right State-Licensing Questions

For a manufacturer or distributor, the correct analysis is therefore not simply, “Is this an FDA medical device?”

The analysis should instead ask:

• How does the state define the relevant product category?
• Does the product’s labeling restrict its sale or use?
• Which activities—manufacturing, owning, storing, selling, invoicing, shipping or dispensing—trigger the state law?
• Which agency administers the requirement?

The product label, intended use, distribution model and exact statutory framework must be reviewed together.

Applying the federal definition alone can overlook a required registration—or incorrectly suggest that one is needed.

Manage Product Classification Across States

MDD Options’ Hybrid distribution model is designed to remove much of this state-by-state licensing burden from the manufacturer by placing the relevant U.S. distribution activities within an established, managed operating structure.

Where the Hybrid model is not appropriate, MDD Options can assess how individual states classify the product, identify the applicable agency and registration pathway, and help resolve or manage licensing gaps before they disrupt commercialization.